Barclays raised the firm’s price target on Aveanna (AVAH) to $11 from $9 and keeps an Overweight rating on the shares. The firm upped estimates post the company’s Q4 preannouncement.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH:
- Aveanna price target raised to $11 from $10 at RBC Capital
- Aveanna price target raised to $10 from $9.50 at UBS
- Midday Fly By: Big banks report mixed quarterly results
- Aveanna Healthcare Raises 2025 Outlook, Issues 2026 Guidance
- Aveanna raises FY25 revenue view to $2.425B-$2.445B from more than $2.375B